ZA-37 150 mg (Venlafaxine Extended Release 150 mg)
Pill imprint ZA-37 150 mg has been identified as Venlafaxine hydrochloride extended release 150 mg.
Venlafaxine is used in the treatment of major depressive disorder; hot flashes; anxiety; anxiety and stress; fibromyalgia (and more), and belongs to the drug class serotonin-norepinephrine reuptake inhibitors. Risk cannot be ruled out during pregnancy. Venlafaxine 150 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- ZA-37 150 mg
- Strength:
- 150 mg
- Color:
- Orange & White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Serotonin-norepinephrine reuptake inhibitors
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Zydus Pharmaceuticals USA Inc.
- National Drug Code (NDC):
- 68382-0036
- Inactive Ingredients:
- silicon dioxide
cetostearyl alcohol
gelatin
hypromelloses
microcrystalline cellulose
ethyl acrylate - methyl methacrylate copolymer
sodium lauryl sulfate
magnesium silicate
titanium dioxide
ferric oxide red
ferrosoferric oxide
| NDC Code | Manufacturer / Repackager |
|---|---|
| 60429-0123 | Golden State Medical Supply (repackager) |
Note: Inactive ingredients may vary.
More about venlafaxine
Consumer resources
- Venlafaxine
- Venlafaxine extended-release capsules
- Venlafaxine extended-release tablets
- Venlafaxine (Advanced Reading)
- Other brands: Effexor, Effexor XR
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
